跳至主要内容
临床试验/JPRN-UMIN000001733
JPRN-UMIN000001733已完成1 期

Pharmacokinetic and clinical analysis of combination chemotherapy with cisplatin and irinotecan in lung cancer patients undergoing hemodialysis: A phase I study - Pharmacokinetic and clinical analysis of combination chemotherapy with cisplatin and irinotecan in lung cancer patients undergoing hemodialysis: A phase I study

iigata Lung Cancer Treatment Group0 个研究点目标入组 16 人开始时间: 2009年2月26日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with other concurrent malignancies, active infections, pulmonary fibrosis, uncontrolled massive pleural effusion or ascites, significant cardiovascular diseases, or symptomatic metastasis to the brain, pregnancy or breast-feeding were excluded.

研究者

发起方
iigata Lung Cancer Treatment Group

相似试验